{"id":815172,"date":"2025-02-19T16:38:10","date_gmt":"2025-02-19T21:38:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/"},"modified":"2025-02-19T16:38:10","modified_gmt":"2025-02-19T21:38:10","slug":"ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/","title":{"rendered":"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PRINCETON, N.J., Feb.  19, 2025  (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present at two upcoming investor conferences as follows:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>Raymond James &amp; Associates\u2019 46<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Institutional Investors Conference<br \/><\/strong>Tuesday, March 4, 2025, at 1:40pm ET<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Leerink Partners Global Healthcare Conference<\/strong><br \/>\n          <br \/>Tuesday, March 11, 2025, at 3:40pm ET<\/li>\n<\/ul>\n<p>The live and archived webcasts will be accessible from the Company\u2019s website at <u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NdB0Eqt2pcuBSitRb_CjcdO9fI51IYel-tNhq7B0kfkLkCVKxIm_jgvE7cDzSUncinFxoL1X13mr2fPB4l7g0TVYLbdQLRcWXG07e04yCE3xjZMlRZZulY0UWfTTGVU4\" rel=\"nofollow\" target=\"_blank\">www.anipharmaceuticals.com<\/a><\/u>, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About ANI Pharmaceuticals, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of \u201cServing Patients, Improving Lives&#8221; by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&amp;D expertise, operational excellence, and U.S.-based manufacturing; and its Established Brands business. For more information, visit\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NdB0Eqt2pcuBSitRb_CjcdO9fI51IYel-tNhq7B0kflsPs6YVtjU4RHGXhx0kNOVLijy3lpwHAwxp6dr3kEFMK642_mzh2-gwcLWOQeGMYu5bYPDVkPBW-_S1jU7wUqQ\" rel=\"nofollow\" target=\"_blank\">www.anipharmaceuticals.com<\/a><\/u>.<\/p>\n<p>\n        <strong>Investor Relations: <\/strong><br \/>\n        <br \/>Lisa M. Wilson, In-Site Communications, Inc.<br \/>T: 212-452-2793 <br \/><strong>E: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0R9kMZ1V_498YjEHUjerP19YKTBgtB5zcvf4-GIwF0Hapi4LZNz0UlsRviUfhNfAUR4FNT1vziEP4bPWODi8p-hpQ6EKwMuZtmFsXMhI5AA=\" rel=\"nofollow\" target=\"_blank\">lwilson@insitecony.com<\/a><\/p>\n<p>\n        <em>Source: ANI Pharmaceuticals, Inc.<\/em>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTBlOWNmMGMtYTYzNS00MTcwLWI1ZjctZGIyMzgxZGFkYTc3LTEwMzA4MzM=\/tiny\/ANI-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present at two upcoming investor conferences as follows: Raymond James &amp; Associates\u2019 46 th Annual Institutional Investors ConferenceTuesday, March 4, 2025, at 1:40pm ET Leerink Partners Global Healthcare Conference Tuesday, March 11, 2025, at 3:40pm ET The live and archived webcasts will be accessible from the Company\u2019s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-815172","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present at two upcoming investor conferences as follows: Raymond James &amp; Associates\u2019 46 th Annual Institutional Investors ConferenceTuesday, March 4, 2025, at 1:40pm ET Leerink Partners Global Healthcare Conference Tuesday, March 11, 2025, at 3:40pm ET The live and archived webcasts will be accessible from the Company\u2019s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its &hellip; Continue reading &quot;ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-19T21:38:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March\",\"datePublished\":\"2025-02-19T21:38:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/\"},\"wordCount\":223,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/\",\"name\":\"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=\",\"datePublished\":\"2025-02-19T21:38:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/","og_locale":"en_US","og_type":"article","og_title":"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March - Market Newsdesk","og_description":"PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) &#8212; ANI Pharmaceuticals, Inc. (\u201cANI\u201d or the \u201cCompany\u201d) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and select members of senior management, will present at two upcoming investor conferences as follows: Raymond James &amp; Associates\u2019 46 th Annual Institutional Investors ConferenceTuesday, March 4, 2025, at 1:40pm ET Leerink Partners Global Healthcare Conference Tuesday, March 11, 2025, at 3:40pm ET The live and archived webcasts will be accessible from the Company\u2019s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its &hellip; Continue reading \"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-19T21:38:10+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March","datePublished":"2025-02-19T21:38:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/"},"wordCount":223,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/","name":"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=","datePublished":"2025-02-19T21:38:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM2MTA2OSM2NzU4NTg2IzIwMTkyNjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/ani-pharmaceuticals-to-present-at-raymond-james-institutional-investors-and-leerink-partners-global-healthcare-conferences-in-march\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ANI Pharmaceuticals to Present at Raymond James\u2019 Institutional Investors and Leerink Partners Global Healthcare Conferences in March"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=815172"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/815172\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=815172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=815172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=815172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}